ALKEM Income Statement - TTM - Alkem Laboratories Limited

Income Statement (TTM)

Alkem Laboratories Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	85,971	87,218	88,650	96,044	100,416	103,425	106,342	104,792	107,586	111,805	115,993	119,906	123,514	126,344	126,676	127,317	128,319	127,566	129,645	133,038
Change (%)		1.45	1.64	8.34	4.55	3.00	2.82	-1.46	2.67	3.92	3.75	3.37	3.01	2.29	0.26	0.51	0.79	-0.59	1.63	2.62
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	34,750	35,282	35,751	39,360	40,596	41,686	42,806	42,813	45,308	47,830	50,207	51,239	51,440	51,996	50,642	49,415	48,192	47,190	49,255	50,207
Change (%)		1.53	1.33	10.10	3.14	2.69	2.69	0.01	5.83	5.57	4.97	2.05	0.39	1.08	-2.60	-2.42	-2.48	-2.08	4.38	1.93
% of Revenue	40.42	40.45	40.33	40.98	40.43	40.31	40.25	40.85	42.11	42.78	43.28	42.73	41.65	41.15	39.98	38.81	37.56	36.99	37.99	37.74

Gross Operating Profit	51,222	51,936	52,899	56,683	59,820	61,739	63,536	61,979	62,278	63,975	65,785	68,667	72,074	74,348	76,034	77,902	80,128	80,376	80,390	82,832
Change (%)		1.40	1.85	7.15	5.53	3.21	2.91	-2.45	0.48	2.72	2.83	4.38	4.96	3.15	2.27	2.46	2.86	0.31	0.02	3.04
% of Revenue	59.58	59.55	59.67	59.02	59.57	59.69	59.75	59.15	57.89	57.22	56.72	57.27	58.35	58.85	60.02	61.19	62.44	63.01	62.01	62.26

SG&A	21,076	21,217	19,807	21,183	22,048	22,660	25,769	25,772	26,536	27,080	29,726	30,081	29,926	30,394	30,324	30,675	31,226	31,753	32,422	33,331
Change (%)		0.67	-6.64	6.95	4.08	2.77	13.72	0.01	2.96	2.05	9.77	1.19	-0.51	1.56	-0.23	1.16	1.80	1.69	2.11	2.81
% of Revenue	24.51	24.33	22.34	22.06	21.96	21.91	24.23	24.59	24.66	24.22	25.63	25.09	24.23	24.06	23.94	24.09	24.33	24.89	25.01	25.05

R&D
Change (%)
% of Revenue

OpEx	69,394	70,092	71,911	78,621	82,780	86,181	88,910	91,314	95,858	99,081	102,797	104,812	105,457	107,112	107,000	105,528	105,262	105,405	108,127	110,288
Change (%)		1.01	2.59	9.33	5.29	4.11	3.17	2.70	4.98	3.36	3.75	1.96	0.62	1.57	-0.10	-1.38	-0.25	0.14	2.58	2.00
% of Revenue	80.72	80.36	81.12	81.86	82.44	83.33	83.61	87.14	89.10	88.62	88.62	87.41	85.38	84.78	84.47	82.89	82.03	82.63	83.40	82.90

Operating Income	16,578	17,126	16,739	17,422	17,635	17,244	17,432	13,479	11,728	12,724	13,196	15,094	18,057	19,231	19,676	21,789	23,058	22,161	21,518	22,750
Change (%)		3.31	-2.26	4.08	1.22	-2.22	1.09	-22.68	-12.99	8.49	3.71	14.38	19.63	6.50	2.31	10.74	5.82	-3.89	-2.90	5.73
% of Revenue	19.28	19.64	18.88	18.14	17.56	16.67	16.39	12.86	10.90	11.38	11.38	12.59	14.62	15.22	15.53	17.11	17.97	17.37	16.60	17.10

Interest Expense	-479	-439	-399	-356	-296	-271	-309	-445	-574	-739	-809	-842	-897	-881	-971	-797	-775	-881	-1,048	-1,054
Change (%)		-8.29	-9.20	-10.63	-17.04	-8.46	14.15	44.16	28.92	28.71	9.51	4.04	6.50	-1.77	10.23	-17.88	-2.73	13.63	18.92	0.64
% of Revenue	-0.56	-0.50	-0.45	-0.37	-0.29	-0.26	-0.29	-0.42	-0.53	-0.66	-0.70	-0.70	-0.73	-0.70	-0.77	-0.63	-0.60	-0.69	-0.81	-0.79

Net Income	14,648	15,338	15,850	16,311	17,033	17,780	16,456	13,051	10,917	10,208	9,842	11,433	14,329	15,732	17,958	20,542	21,223	21,532	21,655	22,846
Change (%)		4.71	3.34	2.91	4.43	4.39	-7.45	-20.69	-16.35	-6.50	-3.59	16.16	25.34	9.79	14.15	14.39	3.32	1.45	0.57	5.50
% of Revenue	17.04	17.59	17.88	16.98	16.96	17.19	15.47	12.45	10.15	9.13	8.48	9.53	11.60	12.45	14.18	16.13	16.54	16.88	16.70	17.17

Source: Capital IQ

Alkem Laboratories Limited - Income Statement (TTM)

Income Statement (TTM)

Other Listings